Rabies Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Rabies Vaccine Manufacturers and it is segmented by Product Type (Baby Hamster Kidney (BHK), Purified Chick Embryo Cell Rabies Vaccine, Vero Cell Rabies Vaccine, Other Product Types), by Vaccination type (Pre-Exposure Vaccination (PEV) and Post-Exposure Prophylaxis (PEP)), by End-User (Animals and Humans), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Rabies Vaccine Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Rabies Vaccine Industry Overview

The major market players are focusing on technological advancements and pet care initiatives in collaboration with hospitals and government channels. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Zoetis Inc., Merck & Co., Inc., Sanofi SA, Elanco, and Virbac, among others.

Rabies Vaccine Market Leaders

  1. Zoetis Inc.

  2. Merck & Co., Inc

  3. Elanco

  4. Sanofi SA

  5. Boehringer Ingelheim International GmbH

  6. *Disclaimer: Major Players sorted in no particular order
Berna Biotech Ltd, GlaxoSmithKline plc, Merck & Co Inc, Novartis AG, Pfizer Inc, Sanofi SA, Zoetis Inc., Elanco